Goldman Sachs Group »

Poseida Therapeutics I shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Poseida Therapeutics I (PSTX) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Poseida Therapeutics I

Tip: Access up to 7 years of quarterly data

All positions including Poseida Therapeutics I held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Poseida Therapeutics I by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.6M 471k 3.36
2023-09-30 $1.1M 467k 2.38
2023-06-30 $439k 250k 1.76
2023-03-31 $904k 293k 3.08
2022-12-31 $682k 129k 5.30
2022-06-30 $116k 45k 2.59
2022-03-31 $253k 57k 4.48
2021-12-31 $531k 78k 6.81
2021-09-30 $416k 57k 7.28
2021-03-31 $375k 39k 9.55
2020-12-31 $461k 42k 10.97
2020-09-30 $322k 36k 8.88